Evidence map›Paper›PMID 38847891›Full record

ArticleNeurogenetics2024

Frequency of C9orf72, GRN, and MAPT pathogenic variants in patients recruited at the Belgrade Memory Center.

Elka Stefanova, Ana Marjanović, Valerija Dobričić, Gorana Mandić-Stojmenović, Tanja Stojković, Marija Branković, Maksim Šarčević, Ivana Novaković, Vladimir S Kostić

Abstract read
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The prevalence of frontotemporal dementia: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elka StefanovaFaculty of Medicine, University of Belgrade, Dr Subotića 8, Belgrade, 11000, Serbia. elka.stefanova@med.bg.ac.rs.ORCID http://orcid.org/0000-0001-5242-1980
Ana MarjanovićFaculty of Medicine, University of Belgrade, Dr Subotića 8, Belgrade, 11000, Serbia.
Valerija DobričićNeurology Clinic, University Clinical Center of Serbia (UCCS), Dr Subotića 6, Belgrade, 11000, Serbia.
Gorana Mandić-StojmenovićFaculty of Medicine, University of Belgrade, Dr Subotića 8, Belgrade, 11000, Serbia.
Tanja StojkovićFaculty of Medicine, University of Belgrade, Dr Subotića 8, Belgrade, 11000, Serbia.
Marija BrankovićFaculty of Medicine, University of Belgrade, Dr Subotića 8, Belgrade, 11000, Serbia.
Maksim ŠarčevićFaculty of Medicine, University of Belgrade, Dr Subotića 8, Belgrade, 11000, Serbia.
Ivana NovakovićFaculty of Medicine, University of Belgrade, Dr Subotića 8, Belgrade, 11000, Serbia.
Vladimir S KostićFaculty of Medicine, University of Belgrade, Dr Subotića 8, Belgrade, 11000, Serbia.

Funding

Wellcome Trust 200110
6 · The paper itself

Abstract

Most of the heritability in frontotemporal dementia (FTD) is accounted for by autosomal dominant hexanucleotide expansion in the chromosome 9 open reading frame 72 (C9orf72), pathogenic/likely pathogenic variants in progranulin (GRN), and microtubule-associated protein tau (MAPT) genes. Until now, there has been no systematic analysis of these genes in the Serbian population. Herein, we assessed the frequency of the C9orf72 expansion, pathogenic/likely pathogenic variants in GRN and MAPT in a well-characterized group of 472 subjects (FTD, Alzheimer's disease - AD, mild cognitive impairment - MCI, and unspecified dementia - UnD), recruited in the Memory Center, Neurology Clinic, University Clinical Center of Serbia. The C9orf72 repeat expansion was detected in 6.98% of FTD cases (13.46% familial; 2.6% sporadic). In the UnD subgroup, C9orf72 repeat expansions were detected in 4.08% (8% familial) individuals. Pathogenic variants in the GRN were found in 2.85% of familial FTD cases. Interestingly, no MAPT pathogenic/likely pathogenic variants were detected, suggesting possible geographical specificity. Our findings highlight the importance of wider implementation of genetic testing in neurological and psychiatric practice managing patients with cognitive-behavioral and motor symptoms.

Indexed as

C9orf72 ProteinFrontotemporal DementiaProgranulinstau ProteinsAgedAged, 80 and overAlzheimer DiseaseCognitive DysfunctionDNA Repeat ExpansionFemaleHumansIntercellular Signaling Peptides and ProteinsMaleMiddle AgedSerbiaC9orf72 ProteinC9orf72 protein, humanGRN protein, humanIntercellular Signaling Peptides and ProteinsMAPT protein, humanProgranulinstau ProteinsAlzheimer’s dementiaFrontotemporal dementiaGeneticsHeritabilityMild cognitive impairmentUnspecified dementia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.